The SpaceX acquisition of xAI closed in early February 2026, creating a combined entity valued around $1.25 trillion and formalizing Elon Musk’s consolidation of rockets, satellites, AI infrastructure, and data platforms under one roof. From a governance and D&O perspective, the deal functions as a fiduciary stress test on the eve of a potential mega‑IPO later this year, with reporting indicating an IPO valuation target as high as $1.5 trillion. The transaction consolidates founder‑controlled entities and imports AI‑related litigation and regulatory risk into SpaceX’s operations, alongside a bold plan to build solar‑powered orbital data centers that would shift AI compute off‑planet. The discussion below highlights governance expectations, litigation exposure, and disclosure considerations D&O underwriters may weigh as the combined company approaches the public markets.

Controller Transactions

Public records indicate that two new Nevada entities were established on January 21, 2026, to facilitate the SpaceX–xAI combination, with Musk the majority shareholder of both. If approvals or key steps in the transaction flow through Nevada entities, the choice of law could materially shift the contours of controlling‑shareholder duties and litigation risk.

Nevada has constructed a comparatively management‑friendly framework. Directors and officers benefit from a statutory business‑judgment presumption, with individual liability generally limited to intentional misconduct, fraud, or knowing violations of law (see Nev. Rev. Stat. § 78.138(7)). Recent updates to Assembly Bill 239 (AB 239) also defined a controlling stockholder’s duties narrowly: the controller’s obligation is essentially to refrain from exerting undue influence that induces a fiduciary breach conferring a material, non‑ratable benefit. Where a conflicted transaction is approved by a committee of disinterested directors, a statutory presumption of no breach applies.

By contrast, Delaware law often applies “entire fairness” in controller conflicts, a more exacting standard that scrutinizes both process and price. Nevada’s approach emphasizes safe harbors and statutory presumptions. Practically, a controlling shareholder like Musk may face fewer fiduciary‑duty claims and enjoy stronger early‑dismissal prospects under Nevada law, because plaintiffs must plausibly allege knowing misconduct rather than unfair dealing alone. Channeling pivotal approvals through Nevada entities can therefore operate as pre‑IPO risk management.

Merger Before IPO

As Matt Levine (“Everything Everywhere Is Securities Fraud”) observed in the public-company context, a merger between two Musk‑controlled entities would ordinarily trigger independent special‑committee oversight, outside advisors, fairness opinions, a stockholder vote, and fulsome disclosure of board deliberations—and “someone would probably own the shares, dislike the merger, and sue.” That observation underscores an important D&O point: while SpaceX is domiciled in Texas with corporate‑friendly statutes (including Senate Bills 29 and 1057), the risk of post‑closing litigation typically increases once public investors enter the capital structure. A public‑company merger between SpaceX and xAI would likely invite challenges to valuation, process, and disclosure, regardless of domicile, and could draw comparisons to prior Musk‑led transactions such as Tesla’s acquisition of SolarCity.

By completing the SpaceX–xAI deal while both companies remain privately held, and now closed, Musk can effectively set relative valuations, negotiate terms within a founder‑controlled ecosystem, close, and then inform investors, without the procedural drag and disclosure obligations that attend a public‑company merger. That flexibility can reduce near‑term execution friction. It does not, however, eliminate fiduciary exposure; rather, it may defer scrutiny to the IPO phase, when investors and regulators will examine how and why the combination occurred, how it was priced, and how related‑party dynamics were managed.

Board Independence

Musk‑led governance has already catalyzed shareholder litigation. D&O Diary readers may be familiar with Tornetta v. Musk, the Delaware Court of Chancery rescinded Tesla’s $51.4 billion CEO pay package and criticized the approval process as insufficiently independent and arm’s‑length. Although SpaceX is not a Delaware corporation, the independence lessons travel. Although SpaceX is not a Delaware corporation, the independence lessons travel.

Post‑merger, xAI has undergone a management reorganization with multiple co‑founder departures, leaving roughly half of the original 12 co‑founders remaining; this raises questions about stability and leadership depth heading into an IPO. Courts, investors, and underwriters increasingly assess independence holistically, looking beyond formal titles to personal relationships, economic ties, historical loyalties, the practical ability to say “no,” and now, leadership continuity. Even in Texas’s business‑court environment, perceived deference to a controller can undermine business‑judgment deference if litigation is filed

For D&O underwriters, the question may be less about where the entity is domiciled and more about whether the record will show a genuinely informed, conflict‑aware process, e.g., special‑committee structuring, advisor selection, benchmarking of valuation, and clear documentation of deliberations. And, perhaps given the turnover, whether talent‑retention plans and succession frameworks have been considered.

Oversight Liability and AI Risk

The acquisition brings xAI’s AI-related litigation and regulatory exposure within SpaceX’s governance perimeter. Allegations tied to content generation (e.g., deepfakes, defamation, or deceptive practices) can trigger suits and regulatory scrutiny. Also, reporting indicates SpaceX has filed an FCC request contemplating up to one million satellites as part of an orbital compute architecture, an ambition that, if pursued, may require robust risk controls and board‑level oversight artifacts.

While Texas has not adopted identical standards to Delaware’s Caremark doctrine, the underlying principle that boards should implement and monitor reasonable systems for risks that go to the core of the business persists. For D&O insurers, the SpaceX-xAI merger demonstrates how AI exposure can be a core operating risk to be addressed by way of pricing, exclusion, or sub‑limits unless governance artifacts demonstrate credible oversight.

Conclusion

The SpaceX–xAI merger illustrates how founder‑controlled, pre‑IPO transactions can operate as both a governance accelerant and a litigation‑risk deferral mechanism and, at this time, takeaways for D&O underwriters include the following.

First, choice of law may have an outsized influence: routing key approvals through Nevada entities may meaningfully recalibrate controller-transaction exposure by replacing Delaware-style entire-fairness scrutiny with statutory business-judgment presumptions and narrow liability standards.

Second, timing matters: consummating a conflicted merger while both companies remain private may reduce near-term process and disclosure friction, but it risks front-loading scrutiny into the IPO phase, where historical valuations, board deliberations, and related-party dynamics can reemerge through securities claims and regulatory review.

Third, board independence may present D&O underwriting exposure regardless of domicile; courts, investors, and insurers are increasingly focused on whether directors can demonstrate genuine arm’s-length oversight in Musk-led transactions.

Finally, the acquisition highlights a growing underwriting issue: AI risk migration. By bringing xAI’s litigation and regulatory exposure inside SpaceX’s governance perimeter, the merger expands oversight obligations into an evolving and unsettled risk domain.

The views expressed in this article are exclusively those of the author, and all of the content in this article has been created solely in the author’s individual capacity. This article is not affiliated with the author’s company, colleagues, or clients. The information contained in this article is provided for informational purposes only, and should not be construed as legal advice on any subject matter.